ClinicalTrials.Veeva

Menu

Efficiency of a Jellyfish Sting Inhibitor Sun Lotion and Protocols for Jellyfish Sting Pain Relief

U

University of Oslo

Status and phase

Completed
Phase 4

Conditions

Pain

Treatments

Other: Nivea sun, caring sun lotion SPF 15
Other: Safe Sea sun lotion with jellyfish sting protection SPF 15

Study type

Interventional

Funder types

Other

Identifiers

NCT00693641
2008-001519-39 (SLV)
2008-02-12-1 (UIO, BIOLOGEN)

Details and patient eligibility

About

The purpose of the study is to investigate the effectiveness of a sun lotion containing a specific Jellyfish sting inhibitor versus regular sun lotions as controls. In addition, to investigate the effectiveness of hot/cold immersion for the treatment of Cyanea sp stings versus local pain relief with prescription free pharmaceutical drug (Xylocain 30 mg/ml (3%) lidocain).

Enrollment

39 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Volunteers
  • men or women
  • aged 18 or over

Exclusion criteria

  • People with atopic diseases, e.g., asthma, allergic rhinorrhea or rhinitis, hay fever, or atopic skin inflammation
  • People who suffer from skin diseases in the testing regions or whose inner forearms are too hairy to allow for interpretation of the test
  • People who have used any medical or cosmetic product on either arm for 48 hours before the start of the experiment
  • People who are taking antihistamines or steroids
  • Subjects with medical conditions which, in the opinion of the investigator, pose risks that would prohibit participating
  • Subjects with a history of keloid formation will be excluded from the Jellyfish protocol
  • Subjects with allergy to lidocain or other local pain substances

If the arms contain hair that might reduce the jellyfish tentacle contact with the skin, the arm must be shaved in advance, so the skin has no sign of piling or any skin damage before the test.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Quadruple Blind

39 participants in 2 patient groups, including a placebo group

1
Active Comparator group
Description:
Safe Sea™ jellyfish sting inhibitor (barrier, or "repellent") lotion
Treatment:
Other: Safe Sea sun lotion with jellyfish sting protection SPF 15
2
Placebo Comparator group
Description:
Regular sun lotion
Treatment:
Other: Nivea sun, caring sun lotion SPF 15

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems